[gnso-gac-closed-generics] Closed Generics Feedback Request - On Mailing List

Sophie Hey sophie.hey at comlaude.com
Wed Apr 12 11:24:07 UTC 2023 

Hi Melissa,

My answers are as follows:

Timeline (email and document from Mary Wong on 3 April attached)

  1.  Are there any objections?
No

  1.  Is anyone opposed to adding a call on 26 April?
     *   If you agree, this will give us 4 calls (12 April, 19 April, 24 April, and 26 April) to work through the strawman document and review the agreed framework outputs before sharing with the broader community.
No opposition to adding a call on 26 April

  1.  I can only make the first 45 minutes of the 19 April call, currently scheduled for 12:30 UTC. Are you opposed to another org staff member stepping in to complete that call?
     *   The alternative is to move the 19 April call to 20:00 UTC the same day and I will be present the entire time.
Happy to do 19 April call at either 1230 or 2000 UTC. If the group favours 1230 UTC, no objection to another org staff member stepping in.

Increasing transparency
Assuming the group agrees upon a framework, once that work is shared with the broader community would you like to increase transparency into the work you’ve done? If so, options include:
Yes, would like to increase transparency into the work we’ve done.

  1.  Open the wiki page, making call recordings and notes publicly available.
Support opening the wiki page, making all call recordings and notes publicly available.

  1.  Allow observers to attend future calls, including the two sessions scheduled for ICANN77.
No objection to this

Sophie Hey
she/her
Policy Advisor
Com Laude
T +44 (0) 20 7421 8250
Ext 252

[cid:image001.png at 01D96D39.9D19AF90]<https://comlaude.com/>
From: gnso-gac-closed-generics <gnso-gac-closed-generics-bounces at icann.org> On Behalf Of Manal Ismail
Sent: Wednesday, April 12, 2023 11:59 AM
To: Melissa Peters Allgood <melissa.allgood at icann.org>; gnso-gac-closed-generics at icann.org
Subject: Re: [gnso-gac-closed-generics] Closed Generics Feedback Request - On Mailing List

Dear Melissa ..

Many thanks for your email ..
Please find my responses inline below in blue ..

Kind Regards
--Manal

From: gnso-gac-closed-generics <gnso-gac-closed-generics-bounces at icann.org<mailto:gnso-gac-closed-generics-bounces at icann.org>> On Behalf Of Melissa Peters Allgood
Sent: Tuesday, April 11, 2023 11:36 PM
To: gnso-gac-closed-generics at icann.org<mailto:gnso-gac-closed-generics at icann.org>
Subject: [gnso-gac-closed-generics] Closed Generics Feedback Request - On Mailing List

Hi all,

In the interest of dedicating our call time to framework substance, I was hoping we could resolve a few outstanding matters on this mailing list. Please respond to each question.

Timeline (email and document from Mary Wong on 3 April attached)

  1.  Are there any objections?
No

  1.  Is anyone opposed to adding a call on 26 April?
     *   If you agree, this will give us 4 calls (12 April, 19 April, 24 April, and 26 April) to work through the strawman document and review the agreed framework outputs before sharing with the broader community.
No opposition to adding a call on 26 April

  1.  I can only make the first 45 minutes of the 19 April call, currently scheduled for 12:30 UTC. Are you opposed to another org staff member stepping in to complete that call?
     *   The alternative is to move the 19 April call to 20:00 UTC the same day and I will be present the entire time.
I’m flexible to join on 19 April at any of the proposed times, 12:30 UTC or 20:00 UTC

Increasing transparency
Assuming the group agrees upon a framework, once that work is shared with the broader community would you like to increase transparency into the work you’ve done? If so, options include:
Yes agree to increasing transparency

  1.  Open the wiki page, making call recordings and notes publicly available.
Not sure whether you mean onwards or retroactively .. Anyway I agree to open up onwards, and retroactively if everyone agrees

  1.  Allow observers to attend future calls, including the two sessions scheduled for ICANN77.
Agree

Please respond with your preferred approach.

Information to share with GNSO Council while you deliberate on substantive framework elements
In the interest of working in parallel with other groups, is there any objection to the following information being shared with GNSO Council while you deliberate on framework elements:

“To the extent this group agrees upon a framework, the expectation is that it will include types of things/information that will be requested of applicants to be included in the application, elements that will be evaluated in the application process, and protections following implementation, likely PICs. The dialogue group is also likely to provide a list of policy areas where the policy process needs to do further work to fill in gaps within the framework.”
Agree

Thank you for your continued dedication. The end is in sight.

Melissa

________________________________
The contents of this email and any attachments are confidential to the intended recipient. They may not be disclosed, used by or copied in any way by anyone other than the intended recipient. If you have received this message in error, please return it to the sender (deleting the body of the email and attachments in your reply) and immediately and permanently delete it. Please note that Com Laude Group Limited (the “Com Laude Group”) does not accept any responsibility for viruses and it is your responsibility to scan or otherwise check this email and any attachments. The Com Laude Group does not accept liability for statements which are clearly the sender's own and not made on behalf of the group or one of its member entities. The Com Laude Group is a limited company registered in England and Wales with company number 10689074 and registered office at 28-30 Little Russell Street, London, WC1A 2HN England. The Com Laude Group includes Nom-IQ Limited t/a Com Laude, a company registered in England and Wales with company number 5047655 and registered office at 28-30 Little Russell Street, London, WC1A 2HN England; Valideus Limited, a company registered in England and Wales with company number 6181291 and registered office at 28-30 Little Russell Street, London, WC1A 2HN England; Demys Limited, a company registered in Scotland with company number SC197176 and registered office at 15 William Street, South West Lane, Edinburgh, EH3 7LL Scotland; Consonum, Inc. dba Com Laude USA and Valideus USA, a corporation incorporated in the State of Washington and principal office address at Suite 332, Securities Building, 1904 Third Ave, Seattle, WA 98101; Com Laude (Japan) Corporation, a company registered in Japan with company number 0100-01-190853 and registered office at 1-3-21 Shinkawa, Chuo-ku, Tokyo, 104-0033, Japan; Com Laude Domain ESP S.L.U., a company registered in Spain and registered office address at Calle Barcas 2, 2, Valencia, 46002, Spain. For further information see www.comlaude.com<https://comlaude.com>
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://mm.icann.org/pipermail/gnso-gac-closed-generics/attachments/20230412/b5ffbc47/attachment-0001.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image001.png
Type: image/png
Size: 8663 bytes
Desc: image001.png
URL: <https://mm.icann.org/pipermail/gnso-gac-closed-generics/attachments/20230412/b5ffbc47/image001-0001.png>

More information about the gnso-gac-closed-generics mailing list